Similar articles

• Treatment of osteoporosis with vitamin D.

  Kanis JA, McCloskey EV, de Takats D, Bernard J, Zhang DM. Kanis JA, et al. Osteoporos Int. 1997;7 Suppl 3:S140-6. doi: 10.1007/BF03194360. Osteoporos Int. 1997. PMID: 9536320 No abstract available.
• Can hypercalcaemia be avoided during oral calcitriol pulse therapy of secondary hyperparathyroidism in haemodialysis patients?

  Szotkiewicz M, Zdrojewski Z, Swima-Gillow A, Rutkowski B. Szotkiewicz M, et al. Nephrol Dial Transplant. 1995;10(9):1781-2. Nephrol Dial Transplant. 1995. PMID: 8559511 No abstract available.
• Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.

  Gallagher JC. Gallagher JC. Metabolism. 1990 Apr;39(4 Suppl 1):27-9. doi: 10.1016/0026-0495(90)90268-h. Metabolism. 1990. PMID: 2325568 Clinical Trial.
• [Serum calcium concentration and the safety of vitamin D therapy].

  Ikeda Y, Takemoto F. Ikeda Y, et al. Clin Calcium. 2004 Sep;14(9):79-82. Clin Calcium. 2004. PMID: 15577116 Review. Japanese.
• Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

  Dechant KL, Goa KL. Dechant KL, et al. Drugs Aging. 1994 Oct;5(4):300-17. doi: 10.2165/00002512-199405040-00006. Drugs Aging. 1994. PMID: 7827399 Review.